Aprazer Healthcare Launched Tudofovir & Ribasure

Posted by

Aprazer Healthcare

September 4, 2025

On December 7, 2017

Product Launch

Aprazer Healthcare Launched Tudofovir 300mg Tablets & Ribasure which is a generic version of Viread (Tenofovir disoproxil ) by Gilead Life Sciences is a medication used to treat chronic hepatitis B and to prevent and treat HIV/AIDS .
Company also launched Ribasure which ( Ribavirin 200 mg ) is a is an antiviral medication used to treat RSV infection, hepatitis C and some viral hemorrhagic fevers.

Newer

Aprazer Healthcare tie up with NATCO PHARMA LIMITED

Older Aprazer Healthcare Launched Entekor 0.5mg & 1mg Tablets

Disclaimer: This medical information is intended only for healthcare professionals in India. The products discussed herein may have different product labeling in other countries. The information within this site is intended to provide balanced, scientific, and evidence-based answers to unsolicited medical questions. For full Prescribing Information including indications, contraindications, warnings, precautions, and adverse events, please submit a medical information request. This information is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of his or her professional license, experience and knowledge of the patient. Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. Any liability for patent infringement is at the buyer's risk. The website does not sell/purchase any medicine.